FindTrial
Sign In

Observation of clinical efficacy and activation of CD4+T cells in patients with herpetic neuralgia by acupuncture at Renying point

Observation of clinical efficacy and activation of CD4+T cells in patients with herpetic neuralgia by acupuncture at Renying point

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006144
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpetic neuralgia

Interventions

control group:nerve block
Acupuncture at Renying point group:Nerve block + acupuncture at Renying point

Sponsors

Xiangcheng People's Hospital of Suzhou
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient was 18-80 years old, with obvious cluster skin rash and blisters, needle-like and burning pain, and VAS=7. The patient was able to objectively evaluate his own pain and complete follow-up

Exclusion criteria

Exclusion criteria: A 80 years old; B excluded patients with drug dependence; C Patients with major depression or serious suicidal tendencies: D persons suffering from serious physical diseases; E Those who cannot adhere to treatment due to distance or other reasons F sick sinus, sinus delay heart disease G skin infection near Renying point H Patients with coagulation disorder

Design outcomes

Primary

MeasureTime frame
CD71;VAS;nAChRa7;—

Secondary

MeasureTime frame
times of pregabalin remedies and total dosage;PHN occurrence rate;Quality of life parameter score;—

Countries

China

Contacts

Public ContactLi Yan
szxcliyan@sina.com13771829585

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026